A comparative study of 114 bilateral total knee arthroplasty outcome in patients between over 80 years old and under 65 years in Chinese population

Author:

Jia Cheng-Qi1,Gao Mei2,Pan Hong-Fa3,Wu Yu-Jie4,Liu Kan5

Affiliation:

1. Beijing Jishuitan Hospital, Capital Medical University

2. Weifang People's Hospital, Shandong Second Medical University

3. Weifang People’s Hospital, Shandong Second Medical University

4. The Third People's Hospital of Datong

5. Beijing University of Chinese Medicine Third Affiliated Hospital

Abstract

Abstract

Background Since China's rapidly growing elderly population, we compared bilateral total knee arthroplasty (BTKA) outcome in patients between over 80 years and under 65 years for reliability, durability, and satisfaction. Methods Between March 2005 and January 2018, 114 patients (228 knees) received BTKA due to osteoarthritis met the inclusion criteria and were postoperatively followed-up ≥ three years. Patients included 83 BTKAs under 65 years (Group 1) and 31 BTKAs over 80 years (Group 2). The indexes included operative data, hemoglobin, Knee Society Score (KSS), Visual Analogue Scale (VAS), Range of Motion (ROM), “Forgotten Joint” Scale (FJS), crutches, patients’ satisfaction, and radiographic examinations. Results The clinical and functional KSS, VAS, and ROM in group 2 improved significantly less than that in group 1 from preoperative mean of 31, 26, 8 and 85° to latest follow-up of 87, 55, 0 and 93°, respectively (p < 0.05). The differences in blood loss and transfusion between two groups were correlated with stages, but not number of hospitalizations (p < 0.05). However, postoperative hemoglobin was correlated with number of hospitalizations, but not stages (p < 0.05). Thirteen patients still used crutches at last follow-up in group 2 (42%). The satisfaction rate in group 2 (90.3%) was lower than 99.4% in group 1 (p < 0.05). The proportion of FJS ≥ 50 was 96.4% in group 1 and 87.1% in group 2 (p < 0.05). Conclusion BTKA was reliable, durable, and satisfied in patients over 80 years in Chinese population, and more blood transfusion should be prepared in patients over 80 years. Level of evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3